Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL RHAMNOLIPID COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/158995
Kind Code:
A1
Abstract:
The present invention provides a novel rhamnolipid compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof. A novel rhamnolipid compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof, according to the present invention, inhibits cancer cell growth by exhibiting cytotoxicity in human cancer cell lines, thereby having an excellent preventative or therapeutic effect especially on the aforementioned cancer.

Inventors:
SHIN HEE JAE (KR)
CHOI BYEOUNG GKYU (KR)
LEE HWA SUN (KR)
LEE HYI SEUNG (KR)
LEE YEON JU (KR)
LEE JONG SEOK (KR)
LEE JI HOON (KR)
PARK CHAN HONG (KR)
Application Number:
PCT/KR2019/002742
Publication Date:
August 06, 2020
Filing Date:
March 08, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOREA INST OCEAN SCI & TECH (KR)
International Classes:
C07H15/04; A23L29/00; A23L33/10; A61K31/7028; A61P35/00; C12P19/44
Domestic Patent References:
WO2017182632A12017-10-26
Foreign References:
CN104877925A2015-09-02
KR20170087877A2017-07-31
Other References:
KRISTOFFERSEN, V. ET AL.: "Characterization of rhamnolipids produced by an arctic marine bacterium from the pseudomonas fluorescence group", MARINE DRUGS., vol. 16, no. 5, 14 May 2018 (2018-05-14), pages 163 - 181, XP055728164
RIKALOVIC, M. G. ET AL.: "Rhamnolipid biosurfactant from Pseudomonas aeruginosa- from discovery to application in contemporary technology", JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, vol. 80, no. 3, 2015, pages 279 - 304, XP055728178
Attorney, Agent or Firm:
KIM, Soon Woong (KR)
Download PDF: